SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2o3b'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FBM_B_RTLB951_0
(PROTEIN (CARTILAGE
OLIGOMERIC MATRIX
PROTEIN))
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
4 / 4 THR A 158
LEU A 162
LEU A 169
GLN A 172
None
0.89A 1fbmA-2o3bA:
undetectable
1fbmA-2o3bA:
9.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FBM_B_RTLB951_3
(PROTEIN (CARTILAGE
OLIGOMERIC MATRIX
PROTEIN))
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
4 / 5 THR A 158
LEU A 162
LEU A 169
GLN A 172
None
0.85A 1fbmE-2o3bA:
undetectable
1fbmE-2o3bA:
9.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ICT_C_T44C128_1
(TRANSTHYRETIN)
2o3b SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
5 / 11 ALA B  70
LEU B  91
LEU B  19
THR B 130
VAL B 114
None
1.07A 1ictA-2o3bB:
undetectable
1ictC-2o3bB:
undetectable
1ictA-2o3bB:
23.87
1ictC-2o3bB:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1WOP_A_FFOA2887_1
(AMINOMETHYLTRANSFERA
SE)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120;
Nostoc
sp.
PCC
7120)
3 / 3 ASP A 130
GLU B  24
ARG A  98
None
MG  A 303 ( 4.0A)
None
0.78A 1wopA-2o3bA:
undetectable
1wopA-2o3bA:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V41_D_BEZD1222_0
(PEROXIREDOXIN 6.)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
4 / 8 PRO A  99
THR A 111
PRO A 112
SER A 113
None
0.98A 2v41C-2o3bA:
undetectable
2v41D-2o3bA:
undetectable
2v41C-2o3bA:
23.51
2v41D-2o3bA:
23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_A_SAMA300_0
(PUTATIVE RRNA
METHYLASE)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
5 / 12 THR A  75
GLY A 123
GLN A 150
ASN A  70
LEU A  67
None
MG  A 303 ( 4.6A)
MG  A 303 ( 4.9A)
None
None
1.09A 3eeyA-2o3bA:
undetectable
3eeyA-2o3bA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_C_SAMC300_0
(PUTATIVE RRNA
METHYLASE)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
5 / 12 THR A  75
GLY A 123
GLN A 150
ASN A  70
LEU A  67
None
MG  A 303 ( 4.6A)
MG  A 303 ( 4.9A)
None
None
1.08A 3eeyC-2o3bA:
undetectable
3eeyC-2o3bA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_D_SAMD300_0
(PUTATIVE RRNA
METHYLASE)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
5 / 12 THR A  75
GLY A 123
GLN A 150
ASN A  70
LEU A  67
None
MG  A 303 ( 4.6A)
MG  A 303 ( 4.9A)
None
None
1.08A 3eeyD-2o3bA:
undetectable
3eeyD-2o3bA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_H_SAMH300_0
(PUTATIVE RRNA
METHYLASE)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
5 / 12 THR A  75
GLY A 123
GLN A 150
ASN A  70
LEU A  67
None
MG  A 303 ( 4.6A)
MG  A 303 ( 4.9A)
None
None
1.17A 3eeyH-2o3bA:
undetectable
3eeyH-2o3bA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPD_B_SAMB1000_1
(UNCHARACTERIZED
PROTEIN MJ0100)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
3 / 3 ASN A 157
ASN A 155
GLU A 163
None
MG  A 303 (-2.8A)
MG  A 303 ( 3.9A)
0.94A 3kpdC-2o3bA:
undetectable
3kpdC-2o3bA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LM8_A_VIBA223_1
(THIAMINE
PYROPHOSPHOKINASE)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
4 / 7 LEU A 103
SER A  72
ASN A  71
THR A 195
None
1.03A 3lm8A-2o3bA:
undetectable
3lm8C-2o3bA:
undetectable
3lm8A-2o3bA:
21.59
3lm8C-2o3bA:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MDT_B_VORB506_1
(CHOLESTEROL
24-HYDROXYLASE)
2o3b SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
5 / 11 LEU B  19
PHE B  29
SER B  16
ALA B  70
THR B  71
None
0.88A 3mdtB-2o3bB:
undetectable
3mdtB-2o3bB:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TTR_A_LQZA90_1
(LACTOTRANSFERRIN)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
3 / 3 PRO A 152
THR A 151
LEU A 234
None
0.70A 3ttrA-2o3bA:
undetectable
3ttrA-2o3bA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FEU_B_KANB301_1
(AMINOGLYCOSIDE
3'-PHOSPHOTRANSFERAS
E APHA1-IAB)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
4 / 7 ASP A 153
ASN A 157
GLU B 111
GLU A 233
None
1.02A 4feuB-2o3bA:
undetectable
4feuB-2o3bA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FEV_B_KANB301_1
(AMINOGLYCOSIDE
3'-PHOSPHOTRANSFERAS
E APHA1-IAB)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
4 / 7 ASP A 153
ASN A 157
GLU B 111
GLU A 233
None
1.11A 4fevB-2o3bA:
undetectable
4fevB-2o3bA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FEW_B_KANB301_1
(AMINOGLYCOSIDE
3'-PHOSPHOTRANSFERAS
E APHA1-IAB)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
4 / 7 ASP A 153
ASN A 157
GLU B 111
GLU A 233
None
1.11A 4fewB-2o3bA:
undetectable
4fewB-2o3bA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FEX_B_KANB301_1
(AMINOGLYCOSIDE
3'-PHOSPHOTRANSFERAS
E APHA1-IAB)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
4 / 7 ASP A 153
ASN A 157
GLU B 111
GLU A 233
None
1.20A 4fexB-2o3bA:
undetectable
4fexB-2o3bA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GKH_D_KAND301_1
(AMINOGLYCOSIDE
3'-PHOSPHOTRANSFERAS
E APHA1-IAB)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
4 / 8 ASP A 153
ASN A 157
GLU B 111
GLU A 233
None
1.08A 4gkhD-2o3bA:
undetectable
4gkhD-2o3bA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WW7_A_ACTA303_0
(EKC/KEOPS COMPLEX
SUBUNIT BUD32)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120;
Nostoc
sp.
PCC
7120)
4 / 4 LEU B 112
VAL B 110
GLU B 111
ARG A 156
None
MES  A 901 (-4.6A)
None
MES  A 901 (-4.8A)
1.49A 4ww7A-2o3bB:
0.0
4ww7A-2o3bB:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JLC_A_1YNA602_1
(LANOSTEROL 14-ALPHA
DEMETHYLASE)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
5 / 12 ALA A 140
TYR A 254
GLY A 184
THR A 195
MET A 148
None
1.03A 5jlcA-2o3bA:
undetectable
5jlcA-2o3bA:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M66_D_ADND502_2
(ADENOSYLHOMOCYSTEINA
SE)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
3 / 3 THR B 135
THR A 200
LEU A 234
MG  A 303 ( 2.9A)
None
None
0.70A 5m66D-2o3bB:
undetectable
5m66D-2o3bB:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OG9_B_TESB502_1
(-)
2o3b NUCLEASE
(Nostoc
sp.
PCC
7120)
5 / 12 LEU A 248
TRP A 159
TRP A 201
ILE A 125
PRO A  45
None
1.04A 5og9B-2o3bA:
undetectable
5og9B-2o3bA:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VCG_A_08YA602_2
(CYTOCHROME P450 3A4)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
3 / 3 ARG B  69
ARG A  93
ARG A 122
MES  A 900 (-4.4A)
None
None
0.70A 5vcgA-2o3bB:
undetectable
5vcgA-2o3bB:
15.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6GNG_B_QPSB601_1
(-)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120)
5 / 12 THR A  75
PRO A  99
VAL B 110
GLU A 163
GLY A 160
None
None
MES  A 901 (-4.6A)
MG  A 303 ( 3.9A)
MES  A 901 (-3.4A)
1.47A 6gngB-2o3bA:
undetectable
6gngB-2o3bA:
18.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NJ9_K_SAMK500_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)
2o3b NUCLEASE
SUGAR-NON-SPECIFIC
NUCLEASE INHIBITOR

(Nostoc
sp.
PCC
7120;
Nostoc
sp.
PCC
7120)
3 / 3 THR A 200
GLU B  24
ASN A 154
None
MG  A 303 ( 4.0A)
None
0.88A 6nj9K-2o3bA:
undetectable
6nj9K-2o3bA:
18.97